RDHL

RedHill Biopharma Ltd.

HealthcareDrug Manufacturers - Specialty & GenericILUSDPeers →Country macro →

$1.03

LiveJun 05, 2026

Market cap

$3.24M

52w range

0.71 – 3.31

P / E

—

EPS

—

Volume

59.82K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on RedHill Biopharma Ltd.’s valuation

○

Insider buys and sells are sourced from SEC Form 4 filings, which cover US-listed issuers. We don't have Form 4 history for this name.

Transactions

0 buys · 0 sells

Bought

Open market

Sold

Open market

Net flow

+$0

Buys − sells

Insider	Role	Action	Shares	Price	Value	Trade date	Filing
No open-market insider activity in this window.

13F position evolution

No 13F history in institutional_holders for RDHL-US.

Pro

Detailed insider buy/sell history is included with Pro.